Mega Fin (India) (532105)
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹10.25 |
| Market Cap | ₹26.14 Cr |
| P/E Ratio | 104.56 |
| ROCE | 10.87% |
| ROE | -10.9% |
| Dividend Yield | 0% |
| Profit Growth | 100% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹30.36 — ₹39.9 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹2.42 |
AI Analysis
AI-generated, general educational analysis — not personal investment advice.
Mega Fin (India) is exactly the kind of micro-cap that requires every rupee to be checked twice. At ₹10.25, I am being asked to pay 104 times earnings for a company whose book value is just ₹2.42 — more than four times book — while the latest quarter reports zero sales and zero net profit. With ROE of -10.90%, shareholder equity is being eroded, not compounded. There is no dividend, no sales growth, and no promoter holding disclosure, so I lack evidence of owner-friendly behavior. The reported 100% profit growth is meaningless on a base of once-again zero profit; it is a low-base illusion. ROCE of 10.87% is a confusing, positive-looking number against a negative ROE and no revenue, so I treat it as an accounting artifact rather than proof of earning power. The Piotroski F-Score of 6/9 is mildly encouraging, but it cannot turn a business with no operating profits into a good investment. Even more troubling, the current price of ₹10.25 lies below the stated 52-week range of ₹25.77–39.90. In a liquid market that discrepancy should not occur; it signals bad data, illiquidity, or a capital event I cannot evaluate. I do not buy what I cannot understand. This is a possible turnaround, but the burden is on management to produce real revenue and sustainable positive ROE. Until then, I will keep this on the too-hard pile.
The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer